Evidence map›Paper›PMID 30131880›Full record

ArticleNPJ vaccines2018

Augmented CD4

Mai-Chi Trieu, Fan Zhou, Sarah Larteley Lartey, Saranya Sridhar, Siri Mjaaland, Rebecca Jane Cox

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in NPJ vaccines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01003288 (Safety and Immunogenicity Studies of Pandemic Influenza), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01003288 nacompletednot on this map

Safety and Immunogenicity Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen

TypeinterventionalSponsorUniversity of BergenRan2009 to 2014Enrolled255ConditionsHealthyArmsAdjuvanted influenza H1N1split virion vaccine
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mai-Chi Trieu1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Fan Zhou1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Sarah Larteley Lartey1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Saranya Sridhar3Jenner Institute, University of Oxford, Oxford, UK.
Siri Mjaaland2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway.
Rebecca Jane Cox1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
University of Bergen · NOJenner Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annual seasonal influenza vaccination is recommended for high-risk populations and often occupational groups such as healthcare workers (HCWs). Repeated annual vaccination has been reported to either have no impact or reduce antibody responses or protection. However, whether repeated vaccination influences T-cell responses has not been sufficiently studied, despite the increasing evidence of the protective roles of T-cell immunity. Here, we explored the impact of repeated annual vaccination with the same vaccine strain (H1N1pdm09) over multiple seasons in the post-2009 pandemic era and showed that repeated vaccination increased both T-cell and humoral responses. Using the T-cell FluroSpot and intracellular cytokine-staining, the hemagglutination inhibition (HI), and the memory B-cell (MBC) ELISpot assays, we investigated pre- and postvaccination T cells, antibodies, and MBCs in a cohort of HCWs repeatedly vaccinated with H1N1pdm09 for 5 years (pandemic vaccination in 2009 and subsequently annual seasonal vaccination containing H1N1pdm09 during 2010-2013). We found that the prevaccination H1N1pdm09-specific T cells, antibodies, and MBCs were significantly increased after 3-4 repeated vaccinations and maintained at high levels throughout seasons 2012 and 2013. The cross-reactive IFN-γ-secreting CD4

Identifiers

PMID30131880
PMCPMC6092382
OpenAlexW2887126762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.